Status:
TERMINATED
Electroconvulsive Treatment Followed by Cognitive Control Training
Lead Sponsor:
University Ghent
Collaborating Sponsors:
University Hospital, Ghent
King Baudouin Foundation
Conditions:
Depressive Episode
Electroconvulsive Therapy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Major depressive disorder (MDD) is worldwide one of the most prevalent and disabling mental health conditions. Electroconvulsive therapy (ECT) is a safe and effective treatment even though 6-month rel...
Detailed Description
Eighty-eight participants aged between 18-70 years with major depressive disorder who start electroconvulsive treatment (ECT) will be included in this randomized controlled trial (RCT). Following (par...
Eligibility Criteria
Inclusion
- aged between 18 and 70 years old
- current major depressive episode with treatment resistance
- eligibility and consent for ECT treatment
- ability to provide consent to study
Exclusion
- neurodegenerative disorder or Montreal Cognitive Assessment (MOCA) \< 18
- catatonia
- schizophrenia
- alcohol use disorder in previous year
- prior ECT treatment
- insufficient computer knowledge or analphabetism
Key Trial Info
Start Date :
May 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04383509
Start Date
May 10 2020
End Date
July 1 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Gent (University Hospital Ghent)
Ghent, Belgium, 9000